Close Menu
TheHub.news

    Where Did the $700 Million Meant to Fight Ebola in Congo Go?

    By Veronika Lleshi

    This Day in History: November 19th

    By TheHub.news Staff

    Black Babies Are Dying at Disproportionate Rates in Milwaukee. The City Wants to Change That

    By Veronika Lleshi

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    X (Twitter) Instagram YouTube
    X (Twitter) Instagram YouTube
    TheHub.news
    Support Our Work
    • Home
    • Our Story
      • News & Views
        • Politics
        • Injustice
        • HBCUs
        • Watch
      • Food
        • Cuisine Noir
        • soulPhoodie
      • Passport Heavy
      • Travel
      • Diaspora
      • This Day
      • Entertainment
      • History
      • Art
      • Music
    • Health
    • Money

      Cashflow Coach: I Planted a Money Tree!

      August 4, 2026

      Breaking Down the 2 Different Types of Income

      July 7, 2026

      Black Americans Are Already Living Through a Recession

      July 6, 2026

      You Must Be an Owner to Win 

      June 23, 2026

      Economic Empowerment Has Always Been a Part of Black History

      February 12, 2026
    • Books
    • Business
    • Sports
      1. First and Pen
      2. View All

      Yolanda Thomas Becomes the First Black Female Coach in NWSL History

      November 16, 2026

      NBA Champ Josh Hart Invests in Italian Club Napoli Basketball

      November 16, 2026

      Democrats Must Engage With Black Athletes to Stop Them From Becoming MAGA Props

      November 10, 2026

      Football HOFer Marshall Faulk Reveals He Has Parkinson’s Disease

      October 26, 2026

      Yolanda Thomas Becomes the First Black Female Coach in NWSL History

      November 16, 2026

      NBA Champ Josh Hart Invests in Italian Club Napoli Basketball

      November 16, 2026

      Democrats Must Engage With Black Athletes to Stop Them From Becoming MAGA Props

      November 10, 2026

      Football HOFer Marshall Faulk Reveals He Has Parkinson’s Disease

      October 26, 2026
    • Tech
    • Podcasts
      1. Karen Hunter is Awesome
      2. Lurie Breaks it Down
      3. Human(ing) Well with Amber Cabral
      4. Financially Speaking
      5. In Class with Carr
      6. View All

      Where Did the $700 Million Meant to Fight Ebola in Congo Go?

      November 19, 2026

      This Day in History: November 19th

      November 19, 2026

      Black Babies Are Dying at Disproportionate Rates in Milwaukee. The City Wants to Change That

      November 18, 2026

      This Day in History: November 18th

      November 18, 2026

      Where Did the $700 Million Meant to Fight Ebola in Congo Go?

      November 19, 2026

      This Day in History: November 19th

      November 19, 2026

      Black Babies Are Dying at Disproportionate Rates in Milwaukee. The City Wants to Change That

      November 18, 2026

      This Day in History: November 18th

      November 18, 2026

      Where Did the $700 Million Meant to Fight Ebola in Congo Go?

      November 19, 2026

      This Day in History: November 19th

      November 19, 2026

      Black Babies Are Dying at Disproportionate Rates in Milwaukee. The City Wants to Change That

      November 18, 2026

      This Day in History: November 18th

      November 18, 2026

      Where Did the $700 Million Meant to Fight Ebola in Congo Go?

      November 19, 2026

      This Day in History: November 19th

      November 19, 2026

      Black Babies Are Dying at Disproportionate Rates in Milwaukee. The City Wants to Change That

      November 18, 2026

      This Day in History: November 18th

      November 18, 2026

      Where Did the $700 Million Meant to Fight Ebola in Congo Go?

      November 19, 2026

      This Day in History: November 19th

      November 19, 2026

      Black Babies Are Dying at Disproportionate Rates in Milwaukee. The City Wants to Change That

      November 18, 2026

      This Day in History: November 18th

      November 18, 2026

      In Class With Carr: “Cuffing Season”

      November 9, 2026

      In Class with Carr: “How to Treat a Trick”

      November 2, 2026

      Exonerated: A Death Row Survivor Says America Is Sacrificing Innocent People to Keep Executions Alive

      October 30, 2026

      In Class With Carr: “Running in Place”

      October 26, 2026
    TheHub.news
    Health

    Trump’s Assault of Executive Orders Locks Out Medication Abortion: This ‘Morning After’ Substitute May Have Opened a Back Door

    By Danielle BennettJanuary 29, 20255 Mins Read
    Share Email Copy Link
    Image credit: ShutterStock
    Share
    Facebook Twitter LinkedIn Email Copy Link Threads

    Over the past several years, the legal battles surrounding the abortion drug mifepristone— particularly its access and availability—have escalated following the Supreme Court’s decision to overturn Roe v. Wade. The pill, approved by the FDA for terminating pregnancies that are less than 60 days in duration when combined with misoprostol, has emerged as the most widely accepted method for medication abortions. According to the Guttmacher Institute (a pro-abortion rights research group), it accounted for over 60% of all abortion procedures in the United States in 2023.

    Even though mifepristone has been successful, it’s still difficult or even impossible to obtain it legally in half of the states in the country after the 1973 landmark ruling on the right to an abortion was repealed in 2022. As a result, many federal lawsuits have threatened access to the pill for those who need it, but now, a new study might have found another option that could work just as well. 

    A known medication called Ella, its active ingredient is ulipristal acetate, it is one of the two types of “morning-after” pills approved by the FDA (the other is Plan B One-Step— it’s active ingredient is levonorgestrel), is at the center of a new study that shows it could be a viable alternative to mifepristone for terminating pregnancies up to ten weeks.

    Published last week in the New England Journal of Medicine, the examination was conducted by researchers at Gynuity Health Projects (a reproductive-rights non-profit), where more than 100 women who were up to nine weeks pregnant took two doses of Ella, followed by misoprostol, which which is a medication commonly used in the standard abortion procedure.

    View this post on Instagram

    A post shared by The 19th (@19thnews)

    The results showed that the method was 97% effective in ending their pregnancies. The data also revealed that there were no serious health issues and concluded that using Ella in this two-drug abortion method was safe. 

    The few women who didn’t succeed completed the process with other medications or procedures. 

    “The success rate of this combined regimen as an abortifacient with minimal additional care needed for ongoing pregnancy, incomplete abortion, or adverse effects is encouraging,” the authors wrote.

    The goal of the study was to determine if the combined use of Ella and misoprostol could provide a safe and effective alternative to current medication abortion regimens, Manuel Bousiéguez, Consulting Associate at Gynuity Health, told MedPage Today. Right now, Ella is only approved by the FDA as an emergency “morning after” pill. However, this study shows that it could be a good alternative to mifepristone and can also safely end an early pregnancy.

    Another positive point is that Ella has a solid background. Not only has it been approved by the FDA, but it has also been available for ten years.

    “The findings open up the possibility that an ulipristal-misoprostol regimen may be a promising option for early medical abortion, with potential for broader application in clinical settings,” Bousiéguez said, adding that this would be especially beneficial “in settings where mifepristone might be inaccessible or restricted.”

    While the research is promising, it might make the already divided views on abortion even more confusing. This is because Ella has mostly been used as emergency contraception, which could lead to misunderstandings about how it differs from abortion. For years, abortion opponents have claimed that “morning-after” pills can cause abortions. In response, experts in reproductive health have pointed out that scientific evidence shows these pills do not end a pregnancy; instead, they prevent pregnancy after sexual intercourse.

    In a related article, Daniel Grossman, MD, from the University of California San Francisco, said that although the “study is promising, a larger trial is needed, preferably one that compares the effectiveness with either the mifepristone-misoprostol or misoprostol-only regimen.” He emphasizes that just looking at the study’s results is not enough “to justify the use of ulipristal acetate in medication abortion outside of a research setting” and that more research is needed.

    Nevertheless, Grossman did point out that exploring alternatives may be helpful if mifepristone becomes even more restricted in the U.S.

    View this post on Instagram

    A post shared by The News Movement (@thenewsmovement)

    “However, there is a risk that the findings of this study could be misapplied and used by politicians to try to restrict ulipristal for emergency contraception,” he wrote. “Any efforts to limit access to ulipristal’s use as an emergency contraceptive would be detrimental to patients.”

    Perrigo, the maker of Ella, released a statement explaining that the recent study used a higher dose (two doses) of ulipristal acetate than what is in one Ella pill and also combined it with misoprostol. They emphasized that “There continues to be no evidence to show that, on its own, Ella causes an abortion.” Perrigo also added that “Ella is an F.D.A.-approved emergency contraception pill that acts before pregnancy can occur.”

    Additionally, The Times has reported that in Europe, researchers like Dr. Rebecca Gomperts, a Dutch doctor who started telemedicine groups that supply abortion pills worldwide, are looking into using low doses of mifepristone as a weekly birth control pill. Dr. Gomperts mentioned that she thinks the new study on Ella is enough to allow her to prescribe the drug for purposes other than what it’s officially approved for, along with misoprostol.

    Dr. Paul Blumenthal, an emeritus professor of obstetrics and gynecology at Stanford University, who was in an advisory group for the study, agrees.

    “The more uses we have for these medications,” he says to The Times, “the harder it will be for people to take them away.”

    birth control Health medical abortion morning after pill Thehub.news Wellness
    Danielle Bennett
    • Instagram

    Danielle Bennett, a hairstylist of 20 years, is the owner of The Executive Lounge, a hair salon that caters to businesswomen, located in the Chelsea neighborhood of New York City. She specializes in natural hair care, haircuts, color, hair weaving and is certified in non-surgical hair replacement. Danielle partners with her clients to provide customized services, while she pampers them with luxury products and professional, private accommodations. “The Executive Lounge is your home away from home; it is a tranquil, modern sanctuary where you matter. Your time is valued and your opinion counts. Why? Because you deserve it.” - Danielle Bennett

    Related Stories

    Health Insurance Is Becoming a Luxury for Millions of Americans

    June 17, 2026

    How to Go Plastic-free (Almost) Overnight

    May 13, 2026

    When the Vapors Came Back: From Biz Markie’s Rap Song to Battery Smoke and Broken Lungs

    April 22, 2026

    How Cory Booker Got Ready for a 25-hour Fight for Our Freedom

    April 9, 2025

    Wellness Wednesday: Your Healthy Travel Pack

    March 19, 2025

    New Health Data Reveals That Even Adults Are Now at Risk for Childhood Diseases 

    February 5, 2025
    Recent Posts
    • Where Did the $700 Million Meant to Fight Ebola in Congo Go?
    • This Day in History: November 19th
    • Black Babies Are Dying at Disproportionate Rates in Milwaukee. The City Wants to Change That
    • This Day in History: November 18th
    • Here’s Why Women Belong in All the Places Where National Security Decisions Are Made

    Where Did the $700 Million Meant to Fight Ebola in Congo Go?

    By Veronika Lleshi

    This Day in History: November 19th

    By TheHub.news Staff

    Black Babies Are Dying at Disproportionate Rates in Milwaukee. The City Wants to Change That

    By Veronika Lleshi

    This Day in History: November 18th

    By TheHub.news Staff

    Subscribe to Updates

    A free newsletter delivering stories that matter straight to your inbox.

    About
    About

    TheHub.news is a storytelling and news platform committed to telling our stories through our lens. With facts at the center, we document the lived reality of our experience globally—our progress, our challenges, and our impact—without distortion, dilution, or apology.

    X (Twitter) Instagram YouTube

    Where Did the $700 Million Meant to Fight Ebola in Congo Go?

    By Veronika Lleshi

    This Day in History: November 19th

    By TheHub.news Staff

    Black Babies Are Dying at Disproportionate Rates in Milwaukee. The City Wants to Change That

    By Veronika Lleshi

    This Day in History: November 18th

    By TheHub.news Staff

    Subscribe to Updates

    A free newsletter delivering stories that matter straight to your inbox.

    © 2026 TheHub.news A 501(c)(3) tax-exempt organization.

    Type above and press Enter to search. Press Esc to cancel.